China Journal of Leprosy and Skin Diseases ›› 2023, Vol. 39 ›› Issue (3): 212-217.doi: 10.12144/zgmfskin202303212

• Reviews • Previous Articles     Next Articles

Update of PD-1/PD-L1 inhibitors in the treatment of skin malignant cancer

CHEN Qi, YANG Jiayi, WANG Xiuli   

  1. Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China
  • Online:2023-03-15 Published:2023-02-16

PDF (PC)

77

Like

Abstract: Immune checkpoint inhibitor programmed cell death protein 1 and its ligand 1 (PD-1/PD-L1) are important targets of the treatment for skin cancer in recent years. The update of PD-1/PD-L1 inhibitors in the treatment of skin malignant cancer is reviewed in this paper.

Key words: skin cancer, immune checkpoint inhibitor, PD-1/PD-L1